Papers
2
Total Citations
35
H-Index
2
About
Dr. Jiangfa Li is a pioneering hepatobiliary and pancreatic surgeon whose work is reshaping the landscape of minimally invasive surgical oncology. His primary research focuses on the comparative effectiveness and safety of robotic, laparoscopic, and open surgical approaches for complex abdominal cancers, particularly pancreatic and liver malignancies. Dr. Li’s major contributions include providing critical evidence that robotic pancreatoduodenectomy (RPD) is both a safe and feasible alternative to traditional open surgery, challenging long-held clinical skepticism. His landmark 2022 study, which directly compared outcomes across open, laparoscopic, and robotic techniques, has garnered 32 citations, underscoring its influence on surgical decision-making. Furthermore, Dr. Li has advanced the field of repeat liver surgery, demonstrating the novel application of the da Vinci robotic system for recurrent hepatocellular carcinoma (HCC). This work offers a less invasive option for patients facing challenging re-operations. By systematically evaluating perioperative data and patient outcomes, Dr. Li is not only validating new technologies but also setting new benchmarks for safety and efficacy in high-stakes surgical procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2